+31 (0) 71 332 2866

VitroScan launches lung cancer trial

VitroScan launches lung cancer trial

VitroScan is thrilled to announce the launch of a new clinical trial for lung cancer patients. Our predictive tumor testing platform will be used to assess the correlation of the 'VitroScan Selection Factor' for immunotherapy and clinical response to these drugs for lung cancer patients. VitroScan kicked off the trial with pulmonary oncologists, thoracic surgeons and their research teams from the Leiden University Medical Center, Groene Hart Ziekenhuis, Alrijne Ziekenhuis, Reinier de Graaf Ziekenhuis, Catharina Ziekenhuis and Slingeland Ziekenhuis. We are excited to see the first results and their potential to advance care for lung cancer patients. Stay tuned for updates and results!
 

Home > News & Events > VitroScan launches lung cancer trial